• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌的综合基因组特征分析。

Integrated genomic characterization of endometrial carcinoma.

出版信息

Nature. 2013 May 2;497(7447):67-73. doi: 10.1038/nature12113.

DOI:10.1038/nature12113
PMID:23636398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3704730/
Abstract

We performed an integrated genomic, transcriptomic and proteomic characterization of 373 endometrial carcinomas using array- and sequencing-based technologies. Uterine serous tumours and ∼25% of high-grade endometrioid tumours had extensive copy number alterations, few DNA methylation changes, low oestrogen receptor/progesterone receptor levels, and frequent TP53 mutations. Most endometrioid tumours had few copy number alterations or TP53 mutations, but frequent mutations in PTEN, CTNNB1, PIK3CA, ARID1A and KRAS and novel mutations in the SWI/SNF chromatin remodelling complex gene ARID5B. A subset of endometrioid tumours that we identified had a markedly increased transversion mutation frequency and newly identified hotspot mutations in POLE. Our results classified endometrial cancers into four categories: POLE ultramutated, microsatellite instability hypermutated, copy-number low, and copy-number high. Uterine serous carcinomas share genomic features with ovarian serous and basal-like breast carcinomas. We demonstrated that the genomic features of endometrial carcinomas permit a reclassification that may affect post-surgical adjuvant treatment for women with aggressive tumours.

摘要

我们使用基于阵列和测序的技术对 373 例子宫内膜癌进行了综合基因组、转录组和蛋白质组学特征分析。子宫浆液瘤和大约 25%的高级别子宫内膜样肿瘤有广泛的拷贝数改变,很少有 DNA 甲基化变化,雌激素受体/孕激素受体水平低,并且频繁发生 TP53 突变。大多数子宫内膜样肿瘤有很少的拷贝数改变或 TP53 突变,但经常发生 PTEN、CTNNB1、PIK3CA、ARID1A 和 KRAS 突变,以及 SWI/SNF 染色质重塑复合物基因 ARID5B 的新突变。我们鉴定的子宫内膜肿瘤亚组具有明显增加的颠换突变频率和 POLE 中新增的热点突变。我们的结果将子宫内膜癌分为四类:POLE 超突变型、微卫星不稳定高突变型、拷贝数低型和拷贝数高型。子宫浆液性癌与卵巢浆液性癌和基底样乳腺癌具有共同的基因组特征。我们证明了子宫内膜癌的基因组特征可以进行重新分类,这可能会影响具有侵袭性肿瘤的女性手术后的辅助治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/5cb590953620/41586_2013_Article_BFnature12113_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/3bb0dad971a2/41586_2013_Article_BFnature12113_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/937a36dec470/41586_2013_Article_BFnature12113_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/e065450060b4/41586_2013_Article_BFnature12113_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/3ec7fceabd07/41586_2013_Article_BFnature12113_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/5cb590953620/41586_2013_Article_BFnature12113_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/3bb0dad971a2/41586_2013_Article_BFnature12113_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/937a36dec470/41586_2013_Article_BFnature12113_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/e065450060b4/41586_2013_Article_BFnature12113_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/3ec7fceabd07/41586_2013_Article_BFnature12113_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f819/7449520/5cb590953620/41586_2013_Article_BFnature12113_Fig5_HTML.jpg

相似文献

1
Integrated genomic characterization of endometrial carcinoma.子宫内膜癌的综合基因组特征分析。
Nature. 2013 May 2;497(7447):67-73. doi: 10.1038/nature12113.
2
Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.根据癌症基因组图谱(The Cancer Genome Atlas,TCGA)亚组,定制设计的下一代 DNA 测序基因面板在分子水平上对子宫内膜癌进行分类的效用。
BMC Med Genomics. 2020 Nov 30;13(1):179. doi: 10.1186/s12920-020-00824-8.
3
Molecular Genetics of Endometrial Carcinoma.子宫内膜癌的分子遗传学。
Annu Rev Pathol. 2019 Jan 24;14:339-367. doi: 10.1146/annurev-pathol-020117-043609. Epub 2018 Oct 17.
4
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.具有体细胞 POLE 外切酶结构域突变的子宫内膜癌的临床病理分析。
Mod Pathol. 2015 Apr;28(4):505-14. doi: 10.1038/modpathol.2014.143. Epub 2014 Nov 14.
5
High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.POLE 基因突变在同期子宫内膜癌和卵巢癌中的高频发生。
Hum Pathol. 2019 Mar;85:92-100. doi: 10.1016/j.humpath.2018.11.001. Epub 2018 Nov 15.
6
Molecular profiling and molecular classification of endometrioid ovarian carcinomas.子宫内膜样卵巢癌的分子谱分析和分子分类。
Gynecol Oncol. 2019 Sep;154(3):516-523. doi: 10.1016/j.ygyno.2019.07.012. Epub 2019 Jul 21.
7
Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.具有神经内分泌特征的去分化子宫内膜癌:临床病理、免疫组织化学和分子遗传学研究。
Hum Pathol. 2018 Feb;72:100-106. doi: 10.1016/j.humpath.2017.11.006. Epub 2017 Nov 11.
8
Use of mutation profiles to refine the classification of endometrial carcinomas.利用突变谱图来完善子宫内膜癌的分类。
J Pathol. 2012 Sep;228(1):20-30. doi: 10.1002/path.4056. Epub 2012 Jul 18.
9
Mutational heterogeneity in non-serous ovarian cancers.非浆液性卵巢癌中的突变异质性。
Sci Rep. 2017 Aug 29;7(1):9728. doi: 10.1038/s41598-017-10432-9.
10
The emerging genomic landscape of endometrial cancer.子宫内膜癌的新兴基因组图谱。
Clin Chem. 2014 Jan;60(1):98-110. doi: 10.1373/clinchem.2013.205740. Epub 2013 Oct 29.

引用本文的文献

1
FOXA2 sensitizes endometrial carcinoma to progestin-mediated conservative therapy by triggering PR transcriptional activation.FOXA2通过触发孕激素受体(PR)的转录激活,使子宫内膜癌对孕激素介导的保守治疗敏感。
Oncogene. 2025 Sep 13. doi: 10.1038/s41388-025-03564-0.
2
Integrating Multi-Omics in Endometrial Cancer: From Molecular Insights to Clinical Applications.子宫内膜癌中的多组学整合:从分子洞察到临床应用
Cells. 2025 Sep 8;14(17):1404. doi: 10.3390/cells14171404.
3
-mutated endometrial cancer: new perspectives on the horizon?- 突变型子宫内膜癌:新的前景展望?

本文引用的文献

1
Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.高级别子宫内膜癌诊断中的观察者间重现性差。
Am J Surg Pathol. 2013 Jun;37(6):874-81. doi: 10.1097/PAS.0b013e31827f576a.
2
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
3
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.胚系突变影响 POLE 和 POLD1 的校对结构域,易导致结直肠腺瘤和癌。
Front Oncol. 2025 Aug 27;15:1633260. doi: 10.3389/fonc.2025.1633260. eCollection 2025.
4
Intratumoral and peritumoral multiparametric MRI-based radiomics nomogram for preoperative risk stratification in patients with endometrial cancer.基于多参数磁共振成像的肿瘤内和肿瘤周围影像组学列线图用于子宫内膜癌患者术前风险分层
Front Oncol. 2025 Aug 26;15:1572784. doi: 10.3389/fonc.2025.1572784. eCollection 2025.
5
Fully-connected network-based prediction model for lymph node metastasis in clinical early-stage endometrial cancer: development and validation in two centers.基于全连接网络的临床早期子宫内膜癌淋巴结转移预测模型:在两个中心的开发与验证
Front Oncol. 2025 Aug 25;15:1627662. doi: 10.3389/fonc.2025.1627662. eCollection 2025.
6
Progress of estrogen receptor and spliceosome in endometrial carcinoma.雌激素受体与剪接体在子宫内膜癌中的研究进展
Front Endocrinol (Lausanne). 2025 Aug 25;16:1586191. doi: 10.3389/fendo.2025.1586191. eCollection 2025.
7
Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.妇科肿瘤学中的免疫检查点抑制剂:现状与展望
Int J Gynaecol Obstet. 2025 Sep;171 Suppl 1:166-188. doi: 10.1002/ijgo.70280.
8
Cancer of the ovary, fallopian tube, and peritoneum: 2025 update.卵巢、输卵管和腹膜癌:2025年更新
Int J Gynaecol Obstet. 2025 Sep;171 Suppl 1:6-35. doi: 10.1002/ijgo.70282.
9
Recurrent FGFR2 and PIK3CA Mutations in Sialoblastoma.涎母细胞瘤中FGFR2和PIK3CA的复发性突变
Head Neck Pathol. 2025 Sep 4;19(1):107. doi: 10.1007/s12105-025-01838-3.
10
Molecular Pharmacological Interventions for Endometrial Cancer: A Comprehensive Review.子宫内膜癌的分子药理学干预:综述
Drug Des Devel Ther. 2025 Aug 27;19:7381-7392. doi: 10.2147/DDDT.S524181. eCollection 2025.
Nat Genet. 2013 Feb;45(2):136-44. doi: 10.1038/ng.2503. Epub 2012 Dec 23.
4
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.对浆液性子宫内膜肿瘤的外显子组测序鉴定出染色质重塑和泛素连接酶复合物基因中的反复发生的体细胞突变。
Nat Genet. 2012 Dec;44(12):1310-5. doi: 10.1038/ng.2455. Epub 2012 Oct 28.
5
Comprehensive molecular portraits of human breast tumours.人类乳腺肿瘤的全面分子特征图谱。
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
6
Genomic landscape of non-small cell lung cancer in smokers and never-smokers.吸烟者和不吸烟者非小细胞肺癌的基因组图谱。
Cell. 2012 Sep 14;150(6):1121-34. doi: 10.1016/j.cell.2012.08.024.
7
Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.通过全基因组分析鉴定子宫浆液性癌中的分子通路异常。
J Natl Cancer Inst. 2012 Oct 3;104(19):1503-13. doi: 10.1093/jnci/djs345. Epub 2012 Aug 23.
8
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.LRP1B 缺失与高级别浆液性卵巢癌对脂质体多柔比星获得性化疗耐药相关。
Cancer Res. 2012 Aug 15;72(16):4060-73. doi: 10.1158/0008-5472.CAN-12-0203.
9
Comprehensive molecular characterization of human colon and rectal cancer.全面的人类结肠和直肠癌分子特征分析。
Nature. 2012 Jul 18;487(7407):330-7. doi: 10.1038/nature11252.
10
Use of mutation profiles to refine the classification of endometrial carcinomas.利用突变谱图来完善子宫内膜癌的分类。
J Pathol. 2012 Sep;228(1):20-30. doi: 10.1002/path.4056. Epub 2012 Jul 18.